QP 23 - CNS 3: Advances in Glioma, Spine, and Normal Tissue Toxicity

Moderator(s)

• 

  Kelli Pointer, MD, PhD

  Dartmouth Cancer Center
  Lebanon, NH
• 

  Aaron Simon, MD, PhD

  UC Irvine
  Orange, CA

Presentations:

• 10:30 AM – 10:40 AM ET

  Macropathology and Multimodal Magnetic Resonance Image Based Deep Learning Model for Personalized Definition of Target Volume in Patients with Glioma
  

  Presenter: Nie Shulun, MD, PhD – Shandong Cancer Hospital and Institute
• 10:40 AM – 10:50 AM ET

  Defining the Occult Margin in Recurrent Glioblastoma Using Spectroscopic MRI: Implications for Radiation Therapy Volumes
  

  Presenter: Eric Mellon, MD, PhD – University of Miami
• 10:50 AM – 11:00 AM ET

  Histologic Classifier of Radiosensitivity to Spine SBRT
  

  Presenter: Christopher Jackson, MD, MS – Memorial Sloan Kettering Cancer Center
• 11:00 AM – 11:10 AM ET

  Analysis of Late Cognitive Outcomes after Whole Brain Radiotherapy and Radiosurgery for Brain Metastases in the North Central Cancer Treatment Group (NCCTG) N0574 and N107C Clinical Trials
  

  Presenter: Alan Nichol, MD, FRCPC – BC Cancer - Vancouver Centre
• 11:10 AM – 11:20 AM ET

  Clinical Endpoints Correlation with Molecular Features in the NRG Oncology/RTOG 9802 Low-Grade Glioma, Low-Risk Observation Arm
  

  Presenter: Jessica Fleming, PhD – The Ohio State University
• 11:20 AM – 11:30 AM ET

  Metabolic Profiling of Adult and Pediatric Glioma Tumor Samples Uncovers Intrinsic Metabolic Differences between Adult Glioblastomas and Pediatric High-Grade Histone H3 Mutant Gliomas
  

  Presenter: Vladislav Sviderskiy, MD, PhD – Washington University School of Medicine in St. Louis